Consort Medical appoints Andrew Hosty to Board as Non-Executive Director

– UK – Consort Medical plc is pleased to announce the appointment of Andrew Hosty as a non executive director of the Company, effective immediately. Mr Hosty joins the Nomination, Audit and Remuneration Committees.

Following the appointment of Andrew Hosty, and as previously highlighted on 1 April 2014, Dr Lynn Drummond has now stepped down from the Board.

Andrew Hosty is Chief Operating Officer at Morgan Advanced Materials plc, an appointment he has held since February 2013. Prior to this Andrew was Chief Executive Officer of Morgan Ceramics and joined the Morgan Advanced Materials plc Board in July 2010. Before this he held a number of senior positions within Morgan Advanced Materials.  Andrew is also a non executive director of British Ceramic Research Limited. Previously Andrew was a non executive director of Fiberweb plc from 2012 to 2013 and President of the British Ceramics confederation from 2003 to 2005.

Peter Fellner, Chairman of Consort Medical plc, comments: “The Board welcomes Andrew’s appointment.  He brings broad operational experience and an outstanding knowledge of advanced manufacturing processes and technologies, which we believe will be of great utility to the Company.

“The Board would also like to thank Lynn for her valuable contribution to the Company during the past three years, and wishes her every success in the future.”

About Consort Medical Plc

Consort Medical plc is an international medical devices company, focused on developing and manufacturing disposable medical devices for drug delivery. The principal business of the Company is the management of Bespak, a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.

The Group has facilities in King’s Lynn, Cambridge, Nelson and Hemel Hempstead in the UK. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT).

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.